Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease
Wenxin Wang(University College Dublin), Xiaohui Song(Wuhan University), Yan‐Xiao Ji(Wuhan University), Juan Yang(Wuhan University), Manli Hu(Wuhan University), Xuewei Huang(Wuhan University), Juan‐Juan Qin(Wuhan University), Jingjing Cai(Central South University), Zhi‐Gang She(Wuhan University), Hailong Yang(Central South University), Ye-Mao Liu(Wuhan University), Haomiao Li(Wuhan University), Peng Zhang(Zhongnan Hospital of Wuhan University), Xiaojing Zhang(Peking University), Hongliang Li(Wuhan University), Xingyuan Zhang(Wuhan University), Hui Liu(Wuhan University), Ze Chen(Tianjin Medical University General Hospital), Lihua Zhu(Wuhan University), Feng Zhou(Wuhan University), Yan-Ci Zhao(Wuhan University), Fang Lei(Wuhan University), Weifang Liu(Wuhan University)
Cited by 223
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
A high performance sulfur-doped disordered carbon anode for sodium ion batteries
|Energy & Environmental Science|2015|636
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Ultrahigh Phosphorus Doping of Carbon for High‐Rate Sodium Ion Batteries Anode
|Advanced Energy Materials|2021|248